The FDA said the council is intended to improve accountability and transparency as biologic products grow increasingly complex, particularly in cell and gene therapy, a sector that has seen rapid regulatory expansion in recent years. FDA forms post-market Safety Council to enhance independent oversight of vaccines and gene therapies, boosting accountability and transparency.